Cargando…

Mitochondrial Dysfunction in Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by recessive mutations in the SMN1 gene, globally affecting ~8–14 newborns per 100,000. The severity of the disease depends on the residual levels of functional survival of motor neuron protein, SMN. SMN is a ubiquitously e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilio, Eleonora, Piano, Valentina, Wirth, Brunhilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503857/ https://www.ncbi.nlm.nih.gov/pubmed/36142791 http://dx.doi.org/10.3390/ijms231810878

Ejemplares similares

Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein
por: Martinez-Carrera, Lilian A., et al.
Publicado: (2015)

Tongue fasciculations in an infant with spinal muscular atrophy type 1
por: Giannopoulou, Eleni Z, et al.
Publicado: (2015)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy
por: Habets, Laura E, et al.
Publicado: (2021)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy
por: Walsh, Melissa B., et al.
Publicado: (2020)

Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy – A pilot study
por: Kruse, Teresa, et al.
Publicado: (2020)

Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2018)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis
por: Janzen, Eva, et al.
Publicado: (2018)

Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models
por: Buettner, Jannik M., et al.
Publicado: (2021)

Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
por: Gollapalli, Kishore, et al.
Publicado: (2021)

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2018)

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2020)

Advances and limitations for the treatment of spinal muscular atrophy
por: Day, John W., et al.
Publicado: (2022)

Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
por: Ahmad, Saif, et al.
Publicado: (2016)

Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017)

Splice-Switching Therapy for Spinal Muscular Atrophy
por: Meijboom, Katharina E., et al.
Publicado: (2017)

Revisiting the role of mitochondria in spinal muscular atrophy
por: James, Rachel, et al.
Publicado: (2021)

The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap
por: Brown, Sharon J., et al.
Publicado: (2022)

UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy
por: Shorrock, Hannah K, et al.
Publicado: (2018)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
por: Hauke, Jan, et al.
Publicado: (2009)

Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice
por: Strathmann, Eike A., et al.
Publicado: (2018)

Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy
por: Hashizume, Atsushi, et al.
Publicado: (2017)

Objective measurement of oral function in adults with spinal muscular atrophy
por: Kruse, T., et al.
Publicado: (2023)

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
por: Jablonka, Sibylle, et al.
Publicado: (2022)

Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy
por: Banno, Haruhiko, et al.
Publicado: (2009)

Biomarkers in Rare Disorders: The Experience with Spinal Muscular Atrophy
por: Tiziano, Francesco D., et al.
Publicado: (2010)

Proximal spinal muscular atrophy: current orthopedic perspective
por: Haaker, Gerrit, et al.
Publicado: (2013)

miRNA in spinal muscular atrophy pathogenesis and therapy
por: Magri, Francesca, et al.
Publicado: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017)

Current and emerging treatment options for spinal muscular atrophy
por: Farooq, Faraz, et al.
Publicado: (2015)

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy
por: Li, Yang-Jean, et al.
Publicado: (2020)

Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
por: Keinath, Melissa C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_403uqoomceea70lkf8dqbqm3fq